4th Annual
  Pharmaceutical PLM
 Maximising return on investment through product life cycle management

      3rd - 4th Ma...
Conference Introduction
                                                                                     4th Annual Ph...
Day 1
                                                                                                           4th Annua...
Day 2
                                                                                            4th Annual Pharmaceutica...
Registration Form
                                                                                                        ...
Upcoming SlideShare
Loading in...5
×

4th Annual Pharmaceutical Plm (2010) Ta

723

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
723
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
7
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "4th Annual Pharmaceutical Plm (2010) Ta"

  1. 1. 4th Annual Pharmaceutical PLM Maximising return on investment through product life cycle management 3rd - 4th March 2010, BSG Conference Centre, London, UK BOOK NOW! Key Speakers Jonathan Deutsch, Director Pharma Development Safety, Licensing and Early Development, Hoffmann-La Roche Maciej Gil, Medical & Regulatory Director & CIS, Eli Lilly Russia Mario Maio, Head of Formulation & Process Development , Merck Serono James Down, Vice President, Product Lifecycle Management, Beckton Dickinson Ralph C. Schimmer, Global Head Drug Safety Sciences - Metabolism and Cardiovascular, Hoffmann-La Roche Vishal K. Gupta, Director Pharmaceutical R&D, Covidien Alok Aggarwal, Co-Founder and Chairman, Evalueserve Alexandra C. Gruber, Director Business Development & Marketing, BIOCRATES Life Sciences Mike Rea, Chief Executive Officer, IdeaPharma Peter G Nielsen, Executive Vice President of Pharmaceutical Development and Chemistry Manufacturing & Control, Lifecycle Pharma Nigel Stoate, Partner, Taylor Wessing Paul FitzGerald, Owner, Syntropy Medica Organised By Driving the Industry Forward | www.futurepharmaus.com Media Partners To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/plm2010
  2. 2. Conference Introduction 4th Annual Pharmaceutical PLM 3rd - 4th March 2010, London, UK Media Partners: Dear Colleague, PharmiWeb.com is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading Pharmaceutical and biopharmaceutical companies are under severe pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features, pressure to improve product pipelines, accelerate time to market, events listings and international jobs to industry professionals across Europe and the US. and improve margins on existing products, while maintaining strict For further information please email: corporate@pharmiweb.com adherence to quality principles and regulatory requirements. It is BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. imperative that pharmaceutical and biotech companies address It is based and located in Warsaw, Poland. Biotechnology World was these business challenges to stay competitive, increase revenue, founded in 2007 to provide the world’s biotech and pharma information and market to enhance profit, and reduce the risk of noncompliance. make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will isiongain 4th Annual Pharmaceutical PLM Conference will feature V allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of keynote addresses, presentations, case studies and interactive the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector discussions from development to commercialisation, quality control, in Europe to global biotechnology, pharmaceutical and life science activities. supplier issues, regulation and inspection. Please be sure to register For further information please visit www.biotechnology-europe.com your participation amongst the industry’s elite for this intensive two- Future Pharmaceuticals has forged powerful relationships with Driving the Industry Forward | www.futurepharmaus.com day of learning, networking and exploiting business opportunities. key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan I look forward to seeing you all in London. implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Best regards Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries’ top issues and the solutions top-tier vendors can provide. For further information please visit: www.futurepharmaus.com InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to Logadassen Curoopen InPharmjobs.com, Pharmafile and Pharmafocus. Conference Producer For further information please visit: www.In-Pharm.com ‘Pharma Connections Worldwide® is the leading professional business networking website focused in the Pharmaceutical, Biotechnology and Life Sciences research industry. Our goal is to provide a conduit for delivery of premiere content coupled with the right clientele in order to facilitate business development opportunities among industry professionals responsible for making key decisions in a global marketplace. ‘ For further information please visit: www.pharmaconnections.com Who should attend? Vice/Presidents, Directors, Heads of:- About visiongain: Visiongain is a specialist business information company focused on providing cutting • Lifecycle Management edge products and services across the Pharmaceutical/Biotech, Telecommunications, Defence and Finance sectors, which include reports, conferences, online daily news and • Portfolio Management Research & Development offline news analysis and bespoke consultancy. With a commitment to innovation and excellence, visiongain offers flexible solutions to meet our clients’ business intelligence needs, providing the right information at the right time to facilitate the commercial • Strategic Planning Partnering decision-making process. Our pharmaceutical products include Pharma Business Daily, the leading daily email newsletter for the pharmaceutical, biotech and healthcare industries, and a range of independent, high-quality, in-depth reports covering focused • Licensing & Alliance and topical areas of concern. Our pharmaceutical conferences address the hottest commercial, regulatory and technical topics and provide an ideal forum for debate and networking for pharmaceutical professionals from around the world. • Process Chemists, Pre-Formulation For further information, please visit: www.visiongain.com • Formulation Clinical Scientists • Clinical Investigators Sponsorship and exhibition opportunities: • Brand Management This event offers a unique opportunity to meet and do business with some of the key players in the pharmaceutical and biotech industries. If you have a • Patent service or product to promote, you can do so at this event by: • Hosting a networking drinks reception • Regulatory Affairs • Taking an exhibition space at the conference Target audience - industry • Advertising in the delegate documentation pack • Providing branded bags, pens, gifts, etc. Pharmaceutical companies, biopharmaceutical If you would like more information on the range of sponsorship or exhibition possibilities for visiongain's 4th Annual Pharmaceutical PLM Conference 2010, companies, software vendors, PLM vendors, Analysts, please contact us: Consultants Christopher Clegg, +44 (0)20 7549 9943 christopher.clegg@visiongainglobal.com
  3. 3. Day 1 4th Annual Pharmaceutical PLM Wednesday 3rd March 2010 09:00 Registration and refreshments 13:40 Enhancing life cycle management through effective pharmaceutical licensing strategies 09:30 Chair’s opening remarks • xamining the licensing process in pharmaceutical industry E 09:40 Evaluating the potential benefit of PLM in drug • eveloping effective strategies while managing costs effectively D development process Jonathan Deutsch Director Pharma Development Safety, Licensing • ccelerating new drug development, introduction, and commercialisation A and Early Development • rioritising new product development and introduction P Hoffmann-La Roche • anaging collaboration with external supply and service networks M 14:20 Effective brand optimisation Mario Maio Head of Formulation & Process Development • Development of intangible value Merck Serono • Planning for PLM - when is early? And when is too late? • Best practice methodologies 10:20 Lifecycle management begins at phase II • Yo-yo marketing – the customer IS king • valuating commercial probability of success in early-stage portfolios E • Putting the ‘life’ in lifecycle • valuating strategic options in phase II E Paul FitzGerald • oadmapping product launch options R Owner • hat ‘great’ looks like: case studies of brands that managed early W Syntropy Medica Mike Rea Chief Executive Officer 15:00 Afternoon refreshments & networking session IdeaPharma 11:00 Morning refreshment & networking session 15:20 Panel discussion: Why new developments are important in injectable delivery today? 11:20 Developing differentiation, innovation, and long- P anelists will identify and understand the growing importance of injectable term growth strategies with lifecycle technologies drug delivery on self-administration, drug formulations, drug-device development, and therapeutic treatment protocols. If you want to submit a • Brief introduction on fundamentals of oral controlled release question, please email it to logadassen.curoopen@visiongain.com • Product innovation through mechanistic changes in product design • Examining drug delivery technologies as growth driver 16:00 Reformulation using new technologies as a strategy • Big pharma and generic company perspective to lifecycle management • Looming patent losses for big pharma • xamples on how new technology and patent protection can maximise E the value of a product. • Examining how emerging markets drive growth • ow the clinical benefit needs to be balanced to the clinical and H Vishal K. Gupta regulatory requirements. Director, Pharmaceutical R&D Covidien • he importance of a timely lifecycle management strategy T Peter G Nielsen 12:00 Maximising ROI through patent protection strategies Executive Vice President of Pharmaceutical Development and • nderstanding how to effectively reassess, develop and exploit patent U Chemistry Manufacturing & Control protection strategies Lifecycle Pharma • nhancing market exclusivity and revenue returns over the lifecycles of E new drugs 16:40 Chair’s closing remarks • Successful case scenarios on strategy application Nigel Stoate Partner 16:50 Networking drinks Taylor Wessing Take your discussions further and build new relationships in a relaxed and informal setting 12:40 Lunch Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2009
  4. 4. Day 2 4th Annual Pharmaceutical PLM Thursday 4th March 2010 09:00 Registration and refreshments 13:40 Evaluating technical and integration issues in PLM • nderstanding the implementation process of PLM solutions U 09:30 Chair’s opening remarks • ustomisation and configuration issues within the pharmaceutical environment C • onfigurable packages versus customised PLM projects C • iscuss successful PLM strategies D 09:40 Mergers and acquisitions: The need for PLM tools James Down • ow does it affect the longer term delivery by the vendors to H Vice President, Product Lifecycle Management the customers? Beckton Dickinson • armonising the product portfolio and enhancing visibility across H the value chain 14:20 Presentation to be announced • anaging portfolio of drug candidates – from research to M Lorna Brazell development and beyond Partner Alok Aggarwal Bird & Bird Co-Founder and Chairman Evalueserve 15:00 Afternoon refreshments & networking session 10:20 Optimising life cycle management through 15:20 Case study - How the integration of Product efficiency measurements Life-cycle Management and manufacturing execution systems (MES) closes the loop between • xplaining why is there a need to measure E manufacturing and design, enabling rapid • dentifying appropriate efficiency measurement tools I innovation cycles while at the same time managing • efining the challenges D the risk, increasing product quality, maximising production yields and decreasing costs. • xploring some best practice examples E Alexandra C. Gruber Director Business Development & Marketing 16:00 Managing drug safety throughout product lifecycle BIOCRATES Life Sciences management • nderstanding the benefit-risk decision making by prescribers and patients U 11:00 Morning refreshment & networking session • daptative design for RMP/REMS based on their outcome A • est practices for developing transparency with safety governance committees B Ralph C. Schimmer Global Head Drug Safety Sciences - Metabolism and Cardiovascular 11:20 Panel Discussion: - The role of partnership in F.Hoffmann-La Roche implementing PLM software P anelists will identify and understand how partnerships with technology 16:40 Complying with regulatory requirements in vendors can maximise value through an efficient PLM implementation. Pharmaceutical life cycle management If you want to submit a question, please email it to • nalysing the increasing pressure by regulatory bodies to ensure drug safety A logadassen.curoopen@visiongain.com • ow FDA requirements and EMEA requirements differ? H • dentifying and reducing risks of non-compliance through PLM I Maciej Gil 12:00 Managing brands across the four phases of Medical & Regulatory Director & CIS product lifecycle Eli Lilly Russia 16:50 Chair’s closing remarks 12:40 Lunch 17:00 End of conference * Invited
  5. 5. Registration Form 4th Annual Pharmaceutical PLM 3rd - 4th March 2010, London, UK Angel For multiple bookings Pentonville Road Photocopy this form Conf. code TA 4th Annual Ci ty Pharmaceutical PLM Ro ad Standard Prices 3rd - 4th March 2010 Old Street Conference only Fee: £1299 VAT: £194.85 Total: £1493.85 Location: SG Conference Centre B Old Street Address: 226-236 City Road City Road Promotional Literature Distribution London EC1V 2TT Distribution of your company’s promotional literature to all conference attendees UK Fee: £999 VAT: £149.85 Total: £1148.85 Details How to book Forename: Surname: Email: conferences@visiongainglobal.com Web: http://www.visiongain.com/plm2010 Job Title: Company: UK Office: Tel: +44(0) 20 7336 6100 Main Switchboard Number: Fax: +44(0) 20 7549 9932 Visiongain Ltd Address: BSG House 226-236 City Road London EC1V 2QY UK Country: Postcode: General information Venue: Directions: BSG Conference Centre 226 – 236 City Road, London, EC1V 2TT. United Phone: Fax: Kingdom. Closest tube station is Old Street (Northern Line). Accommodation: Travelodge London City Road Hotel, 7-12 City Road, London, EC1Y 1AE, Tel: 0871 984 6333, Fax: 0207 628 2503, Email: http://www.travelodge.co.uk/search_and_book/hotel_overview.php?hotel_id=340 Payment terms: Visiongain require the full amount to be paid before the conference. Visiongain Signature: Ltd may refuse entry to delegates who have not paid their invoice in full. A credit card guarantee may be requested if payment has not been received in full before the event. Visiongain Ltd reserves the I confirm that I have read and agree to the terms and conditions of booking right to charge interest on unpaid invoices. Substitutions/name changes or cancellations: There is a 50% liability on all bookings once made, whether by post, fax, email or web. There is a no refund policy for cancellations received on Methods of payment or after one month before the start of the event. Should you decide to cancel after this date, the full invoice must be paid. Conference notes will then be sent to you. Unfortunately, we are unable Payment must be made in sterling to transfer places between conferences and executive briefings. However, if you cannot attend the By Mail: Complete and return your signed registration form together with your cheque payable conference, you may make a substitution/name change at any time, as long as we are informed in writing by email, fax or post. Name changes and substitutions must be from the same company or to Visiongain Ltd and send to: visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY, UK organisation and are not transferable between countries. By Fax: Complete and fax your signed registration form with your credit card details Invoice alterations: There will be an administration charge of £50 for any changes to an invoice, excluding substitutions/name changes, requested by the customer. This will be charged to the to +44 (0) 20 7549 9932 customer by credit card prior to the changes being made. By Phone: Call us on +44 (0) 20 7336 6100 with your credit card details Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled By Credit Card: Fill in your card details below and fax back to +44 (0) 20 7549 9932 due to unforeseen events beyond the control of visiongain Ltd. If such a situation arises, we will try to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or By Bank Transfer: expenses, which may be incurred by the customer as a consequence of the event being postponed or Visiongain Ltd A/C: visiongain Ltd cancelled. We therefore strongly advise all our conference clients to take out insurance to cover the cost of the registration, travel and expenses. Barclays Bank Sort Code: 20-71-64 Data Protection: Visiongain Ltd gathers and manages data in accordance with the Data Piccadilly Branch Account No: 6038 7118 Protection Act 1988. Your personal information contained in this form may be used to update you on 48 Regent Street Swift Code: BARC GB22 visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. We may also share your data with external companies offering complementary products or services. If you London, W1B 5RA IBAN: GB80 BARC 20716460387118 wish for your details to be amended, suppressed or not passed on to any external third party, please send your request to the Database Manager, visiongain Ltd, BSG House, 226-236 City Road, London, Please debit my credit card: EC1V 2QY. Alternatively, you can visit our website at www.visiongain.com and amend your details. Access MasterCard Visa American Express Please allow approximately 30 days for your removal or update request to be applied to our database. Following your removal or update request, you may receive additional pieces of communication from visiongain Ltd during the transitional period, whilst the changes are coming into effect. Fee: The conference fee includes lunch, refreshments and conference papers provided on the day. Card number: This fee does not include travel, hotel accommodation, transfers or insurance, (which we strongly recommend you obtain). VAT: VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT Expiry Date: incurred by contacting Eurocash Corporation plc +44 (0) 1273 325000, eurocash@eurocashvat.com. Eurocash specialise in recovering cross-border VAT. Security number (last 3 digits on back of credit card): How we will contact you: Visiongain Ltd’s preferred method of communication is by email and phone. Please ensure that you complete the registration form in full so that we can contact you. Signature: Unable to attend Cardholder’s name: Obviously nothing compares to being there but you need not miss out. Simply tick the box and send with your payment. You will receive your copy of the event CD Rom two weeks after the event. Yes, please send me a copy of the CD for Price£550 VAT:£82.50 Total:£632.50 News updates Office use only Please tick if you do not want to receive email news updates in the future www.visiongain.com/plm2010

×